SUNP

AcronymDefinition
SUNPSuelo Urbanizable No Programado (Spanish; urban development program)
SUNPSeattle Urban Nature Project (Washington)
References in periodicals archive ?
BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company.
BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company.
BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and affiliates, "Sun Pharma") to purchase all of the issued and outstanding shares of Taro not currently held by Sun Pharma for $24.
BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today sent a letter to Directors of Taro Pharmaceutical Industries Ltd.
BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for generic Fosamax (R), alendronate sodium tablets.
BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today announced that based on the count of votes at Taro Pharmaceutical Industries Ltd.
BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715) today will file an Amendment to its previously announced Tender Offer by its subsidiary, Alkaloida Chemical Company Exclusive Group Ltd.
BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today announced that RiskMetrics Group's ISS Governance Services (RMG), a leading independent proxy advisory firm, recommended that shareholders of Taro Pharmaceutical Industries Ltd.
BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715) today announced it was victorious in all elements of its defense of the litigation brought against it in the Tel-Aviv District Court by Taro Pharmaceutical Industries Ltd.
BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and affiliates, "Sun Pharma") continues to evaluate Sun Pharma's non-binding October 18, 2011 cash offer of $24.
BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today sent a letter to shareholders of Taro Pharmaceutical Industries Ltd.
BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) reported a quarter of strong growth for the first quarter ending June 30, 2008.